GIMV
Overview
No.1 Belgium based investor. Growth equity focus.
Investment Focus
- Companies with high-growth potential
- Entrepreneurial and innovative management teams
- Alignment with one of Gimv's investment platforms
Portfolio Companies
Get the full list of 54,000+ investors
GIMV and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about GIMV
What sectors does GIMV invest in?
GIMV invests in Real Estate, Consumer, FinTech, Transportation, Life Sciences and Medtech, and is based in Antwerpen, Vlaanderen, Belgium. GIMV is listed as a private equity in the ConnectSafely investor database.
What stage does GIMV invest at?
GIMV backs companies at Seed, Series A, Series B, Growth, Buyout and Turnaround, writing cheques of 5M - 75M.
Which regions does GIMV invest in?
GIMV invests across United States, United Kingdom, Germany, France, Italy and Denmark.
Who are the partners at GIMV?
Team members listed for GIMV include Edmond Bastijns (Chief Legal Officer - Secretary General) and Koen Dejonckheere (CEO).
What companies has GIMV invested in?
GIMV's portfolio includes Biotalys, Ceres, Covagen, Digital Insight, Onward, Santhera Pharmaceuticals, Aclara Technologies and Anjarium Biosciences.
How do I contact GIMV?
GIMV's contact details — including work email, phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
